Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
GAVI
Pharma
Clover rejects Gavi demand for $224M repayment on COVID deal
Similar to a previous deal with Novavax, Gavi is asking Clover Biopharmaceuticals for repayment of $224 million in their COVID vaccine partnership.
Kevin Dunleavy
Mar 24, 2025 11:36am
Gavi, UK tap Bavarian Nordic for 650,000 mpox vaccine doses
Sep 19, 2024 9:05am
Gavi-backed AVMA debuts to bolster Africa vaccine production
Jun 21, 2024 9:41am
Novavax paying up to $400M to evade Gavi COVID shot arbitration
Feb 22, 2024 6:00am
Will Novavax survive 2023? Company raises doubts about future
Mar 1, 2023 8:00am
Moderna scraps vax supply deal with COVAX for new 2023 agreement
Oct 17, 2022 10:10am
